Uroveda Institute of Urogenital Diseases

Uroveda Institute of Urogenital Diseases is a specialized biotechnology and healthcare company focused on the research, development, and commercialization of treatments for chronic urogenital conditions. The company integrates traditional knowledge with modern pharmacological standards to address underserved indications such as chronic prostatitis, chronic pelvic pain syndrome (CPPS), and interstitial cystitis. Uroveda's primary business model involves the development of proprietary therapeutic formulations and providing specialized clinical care through its institute. Their flagship products are designed to provide long-term relief for inflammatory and infectious diseases of the male and female urinary and reproductive systems.